The Efficacy and Safety of the Dried Biological Amnion Graft in Patients With Intrauterine Adhesions (NCT02496052) | Clinical Trial Compass
UnknownNot Applicable
The Efficacy and Safety of the Dried Biological Amnion Graft in Patients With Intrauterine Adhesions
China300 participantsStarted 2013-01
Plain-language summary
To estimate the efficacy and safety of dried biological amnion graft after hysteroscopic lysis of intrauterine adhesions.
Who can participate
Age range20 Years – 40 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* age 20-40 years；
* previously diagnostic hysteroscopy confirmed adhesion score \>5， according to the American Fertility Society （AFS）classification of IUA；
* complains of menstruation disorder and reproductive dysfunction；
* informed consent.
Exclusion Criteria:
* premature menopause,
* presence of other intrauterine lesions (e.g. polyps, myoma, septa), and
* presence of severe intercurrent illness (e.g. systemic disease, coagulative disorders, severe kidney and liver diseases),
* adhesions limited to the lower uterine cavity or the cervical canal.